PI-114

N/A

Report date: 2025/01/26 16:45:59

Base Information

Drug NamePI-114
Drug Alias Namemonoclonal antibody (Pionyr Immunotherapeutics)PI-114
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPionyr Immunotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesIkena Oncology Inc
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A